Population pharmacokinetic analysis of raltegravir pediatric formulations in HIV‐infected children 4 weeks to 18 years of age

Publisher: John Wiley & Sons Inc

E-ISSN: 1552-4604|55|7|748-756

ISSN: 0091-2700

Source: JOURNAL OF CLINICAL PHARMACOLOGY (ELECTRONIC), Vol.55, Iss.7, 2015-07, pp. : 748-756

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content